Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Neurodegenerative Diseases Drug industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Teva Pharmaceuticals
Mitsubishi Tanabe Pharma America
UCB SA
Novartis
Roche
ACADIA Pharmaceuticals Inc
Sanofi
Orion Pharma Ltd
Biogen
Lundbeck Pharmaceuticals Italy SpA
Pfizer
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
By Drug Class
Immunomodulator
Interferons
Decarboxylase Inhibitors
Dopamine Agonists
Others
By Route of Administration
Oral
Injection
Transdermal
Application:
Multiple Sclerosis
Parkinson?s Disease
Alzheimer?s Disease
Spinal Muscular Atrophy (SMA)
Others
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Neurodegenerative Diseases Drug Industry Overview
-
1.1.1 Neurodegenerative Diseases Drug Market Scope and Market Segments
-
1.1.2 Neurodegenerative Diseases Drug Industry Characteristics
-
1.1.3 Global and China Neurodegenerative Diseases Drug Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Neurodegenerative Diseases Drug Production Value and Growth Rate (2017-2028)
-
1.2 Global Neurodegenerative Diseases Drug Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 By Drug Class
-
1.2.2 Immunomodulator
-
1.2.3 Interferons
-
1.2.4 Decarboxylase Inhibitors
-
1.2.5 Dopamine Agonists
-
1.2.6 Others
-
1.2.7 By Route of Administration
-
1.2.8 Oral
-
1.2.9 Injection
-
1.2.10 Transdermal
-
1.3 Global Neurodegenerative Diseases Drug Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Multiple Sclerosis
-
1.3.2 Parkinson?s Disease
-
1.3.3 Alzheimer?s Disease
-
1.3.4 Spinal Muscular Atrophy (SMA)
-
1.3.5 Others
-
1.4 Market Analysis by Region
-
1.4.1 North America Neurodegenerative Diseases Drug Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Neurodegenerative Diseases Drug Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Neurodegenerative Diseases Drug Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Neurodegenerative Diseases Drug Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Neurodegenerative Diseases Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Neurodegenerative Diseases Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Neurodegenerative Diseases Drug Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Neurodegenerative Diseases Drug Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Neurodegenerative Diseases Drug Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Neurodegenerative Diseases Drug Industry Porter's Five Forces Model Analysis
-
2.2.3 Neurodegenerative Diseases Drug Industry PEST Analysis
-
2.3 Neurodegenerative Diseases Drug Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Neurodegenerative Diseases Drug Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Neurodegenerative Diseases Drug Industry
Chapter 3 Global and China Neurodegenerative Diseases Drug Market, by Manufacturer
-
3.1 Global and China Neurodegenerative Diseases Drug Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Neurodegenerative Diseases Drug Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Neurodegenerative Diseases Drug Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Neurodegenerative Diseases Drug Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Neurodegenerative Diseases Drug Market Top 3 Players
Chapter 4 Global and China Neurodegenerative Diseases Drug Market, by Type (2017-2028)
-
4.1 Neurodegenerative Diseases Drug Market Trend, by Type
-
4.2 Global Neurodegenerative Diseases Drug Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Neurodegenerative Diseases Drug Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Neurodegenerative Diseases Drug Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Neurodegenerative Diseases Drug Price Trend, by Type (2017-2028)
-
4.3 China Neurodegenerative Diseases Drug Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Neurodegenerative Diseases Drug Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Neurodegenerative Diseases Drug Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Neurodegenerative Diseases Drug Price Trend, by Type (2017-2028)
Chapter 5 Global and China Neurodegenerative Diseases Drug Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Neurodegenerative Diseases Drug Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Neurodegenerative Diseases Drug Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Neurodegenerative Diseases Drug Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Neurodegenerative Diseases Drug Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Neurodegenerative Diseases Drug Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Neurodegenerative Diseases Drug Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Neurodegenerative Diseases Drug Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Neurodegenerative Diseases Drug Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Neurodegenerative Diseases Drug Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Neurodegenerative Diseases Drug Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Neurodegenerative Diseases Drug Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Neurodegenerative Diseases Drug Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Neurodegenerative Diseases Drug Market Analysis
-
7.1 North America Neurodegenerative Diseases Drug Market, by Type
-
7.2 North America Neurodegenerative Diseases Drug Market, by Application
-
7.3 North America Neurodegenerative Diseases Drug Market Analysis and Forecast, by Country
-
7.3.1 United States Neurodegenerative Diseases Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Neurodegenerative Diseases Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Neurodegenerative Diseases Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Neurodegenerative Diseases Drug Market Analysis
-
8.1 Europe Neurodegenerative Diseases Drug Market, by Type
-
8.2 Europe Neurodegenerative Diseases Drug Market, by Application
-
8.3 Europe Neurodegenerative Diseases Drug Market Analysis and Forecast, by Country
-
8.3.1 Germany Neurodegenerative Diseases Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Neurodegenerative Diseases Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Neurodegenerative Diseases Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Neurodegenerative Diseases Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Neurodegenerative Diseases Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Neurodegenerative Diseases Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Neurodegenerative Diseases Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Neurodegenerative Diseases Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Neurodegenerative Diseases Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Neurodegenerative Diseases Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Neurodegenerative Diseases Drug Market Analysis
-
9.1 APAC Neurodegenerative Diseases Drug Market, by Type
-
9.2 APAC Neurodegenerative Diseases Drug Market, by Application
-
9.3 APAC Neurodegenerative Diseases Drug Market Analysis and Forecast, by Country
-
9.3.1 China Neurodegenerative Diseases Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Neurodegenerative Diseases Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Neurodegenerative Diseases Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Neurodegenerative Diseases Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Neurodegenerative Diseases Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Neurodegenerative Diseases Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Neurodegenerative Diseases Drug Market Analysis
-
10.1 Latin America, Middle East and Africa Neurodegenerative Diseases Drug Market, by Type
-
10.2 Latin America, Middle East and Africa Neurodegenerative Diseases Drug Market, by Application
-
10.3 Latin America, Middle East and Africa Neurodegenerative Diseases Drug Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Neurodegenerative Diseases Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Neurodegenerative Diseases Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Neurodegenerative Diseases Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Neurodegenerative Diseases Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Neurodegenerative Diseases Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Neurodegenerative Diseases Drug Company Profiles
-
11.1 Teva Pharmaceuticals
-
11.1.1 Teva Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Teva Pharmaceuticals Neurodegenerative Diseases Drug Product Profiles, Application and Specification
-
11.1.3 Teva Pharmaceuticals Neurodegenerative Diseases Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Mitsubishi Tanabe Pharma America
-
11.2.1 Mitsubishi Tanabe Pharma America Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Mitsubishi Tanabe Pharma America Neurodegenerative Diseases Drug Product Profiles, Application and Specification
-
11.2.3 Mitsubishi Tanabe Pharma America Neurodegenerative Diseases Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 UCB SA
-
11.3.1 UCB SA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 UCB SA Neurodegenerative Diseases Drug Product Profiles, Application and Specification
-
11.3.3 UCB SA Neurodegenerative Diseases Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Novartis
-
11.4.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Novartis Neurodegenerative Diseases Drug Product Profiles, Application and Specification
-
11.4.3 Novartis Neurodegenerative Diseases Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Roche
-
11.5.1 Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Roche Neurodegenerative Diseases Drug Product Profiles, Application and Specification
-
11.5.3 Roche Neurodegenerative Diseases Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 ACADIA Pharmaceuticals Inc
-
11.6.1 ACADIA Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 ACADIA Pharmaceuticals Inc Neurodegenerative Diseases Drug Product Profiles, Application and Specification
-
11.6.3 ACADIA Pharmaceuticals Inc Neurodegenerative Diseases Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Sanofi
-
11.7.1 Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Sanofi Neurodegenerative Diseases Drug Product Profiles, Application and Specification
-
11.7.3 Sanofi Neurodegenerative Diseases Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 Orion Pharma Ltd
-
11.8.1 Orion Pharma Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 Orion Pharma Ltd Neurodegenerative Diseases Drug Product Profiles, Application and Specification
-
11.8.3 Orion Pharma Ltd Neurodegenerative Diseases Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 Biogen
-
11.9.1 Biogen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 Biogen Neurodegenerative Diseases Drug Product Profiles, Application and Specification
-
11.9.3 Biogen Neurodegenerative Diseases Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.10 Lundbeck Pharmaceuticals Italy SpA
-
11.10.1 Lundbeck Pharmaceuticals Italy SpA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.10.2 Lundbeck Pharmaceuticals Italy SpA Neurodegenerative Diseases Drug Product Profiles, Application and Specification
-
11.10.3 Lundbeck Pharmaceuticals Italy SpA Neurodegenerative Diseases Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.11 Pfizer
-
11.11.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.11.2 Pfizer Neurodegenerative Diseases Drug Product Profiles, Application and Specification
-
11.11.3 Pfizer Neurodegenerative Diseases Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Neurodegenerative Diseases Drug Industry Investment Prospect and Risk Assessment
-
12.1 Neurodegenerative Diseases Drug Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Neurodegenerative Diseases Drug Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Neurodegenerative Diseases Drug Sales Volume and Growth Rate (2017-2028)
-
Figure China Neurodegenerative Diseases Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Global Neurodegenerative Diseases Drug Production Value and Growth Rate (2017-2028)
-
Figure China Neurodegenerative Diseases Drug Production Value and Growth Rate (2017-2028)
-
Figure Global Neurodegenerative Diseases Drug Market Size and Growth Rate of By Drug Class (2017-2028)
-
Figure Global Neurodegenerative Diseases Drug Market Size and Growth Rate of Immunomodulator (2017-2028)
-
Figure Global Neurodegenerative Diseases Drug Market Size and Growth Rate of Interferons (2017-2028)
-
Figure Global Neurodegenerative Diseases Drug Market Size and Growth Rate of Decarboxylase Inhibitors (2017-2028)
-
Figure Global Neurodegenerative Diseases Drug Market Size and Growth Rate of Dopamine Agonists (2017-2028)
-
Figure Global Neurodegenerative Diseases Drug Market Size and Growth Rate of Others (2017-2028)
-
Figure Global Neurodegenerative Diseases Drug Market Size and Growth Rate of By Route of Administration (2017-2028)
-
Figure Global Neurodegenerative Diseases Drug Market Size and Growth Rate of Oral (2017-2028)
-
Figure Global Neurodegenerative Diseases Drug Market Size and Growth Rate of Injection (2017-2028)
-
Figure Global Neurodegenerative Diseases Drug Market Size and Growth Rate of Transdermal (2017-2028)
-
Figure Global Neurodegenerative Diseases Drug Market Size and Growth Rate of Multiple Sclerosis (2017-2028)
-
Figure Global Neurodegenerative Diseases Drug Market Size and Growth Rate of Parkinson?s Disease (2017-2028)
-
Figure Global Neurodegenerative Diseases Drug Market Size and Growth Rate of Alzheimer?s Disease (2017-2028)
-
Figure Global Neurodegenerative Diseases Drug Market Size and Growth Rate of Spinal Muscular Atrophy (SMA) (2017-2028)
-
Figure Global Neurodegenerative Diseases Drug Market Size and Growth Rate of Others (2017-2028)
-
Figure North America Neurodegenerative Diseases Drug Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Neurodegenerative Diseases Drug Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Neurodegenerative Diseases Drug Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Neurodegenerative Diseases Drug Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Neurodegenerative Diseases Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Neurodegenerative Diseases Drug Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Neurodegenerative Diseases Drug Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Neurodegenerative Diseases Drug Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Neurodegenerative Diseases Drug Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Neurodegenerative Diseases Drug Market Share, by Manufacturer in 2021
-
Figure Global and China Neurodegenerative Diseases Drug Market Share, by Manufacturer in 2022
-
Table Global Neurodegenerative Diseases Drug Sales Volume, by Type (2017-2028)
-
Table Global Neurodegenerative Diseases Drug Sales Volume Share, by Type (2017-2028)
-
Figure Global Neurodegenerative Diseases Drug Sales Volume Share, by Type (2017-2028)
-
Table Global Neurodegenerative Diseases Drug Sales Value, by Type (2017-2028)
-
Table Global Neurodegenerative Diseases Drug Sales Value Share, by Type (2017-2028)
-
Figure Global Neurodegenerative Diseases Drug Price Trend, by Type (2017-2028)
-
Table China Neurodegenerative Diseases Drug Sales Volume, by Type (2017-2028)
-
Table China Neurodegenerative Diseases Drug Sales Volume Share, by Type (2017-2028)
-
Figure China Neurodegenerative Diseases Drug Sales Volume Share, by Type (2017-2028)
-
Table China Neurodegenerative Diseases Drug Sales Value, by Type (2017-2028)
-
Table China Neurodegenerative Diseases Drug Sales Value Share, by Type (2017-2028)
-
Figure China Neurodegenerative Diseases Drug Price Trend, by Type (2017-2028)
-
Table Global Neurodegenerative Diseases Drug Sales Volume, by Application (2017-2028)
-
Table Global Neurodegenerative Diseases Drug Sales Volume Share, by Application (2017-2028)
-
Figure Global Neurodegenerative Diseases Drug Sales Volume Share, by Application (2017-2028)
-
Table Global Neurodegenerative Diseases Drug Sales Value, by Application (2017-2028)
-
Table Global Neurodegenerative Diseases Drug Sales Value Share, by Application (2017-2028)
-
Figure Global Neurodegenerative Diseases Drug Sales Value Share, by Application (2017-2028)
-
Table China Neurodegenerative Diseases Drug Sales Volume, by Application (2017-2028)
-
Table China Neurodegenerative Diseases Drug Sales Volume Share, by Application (2017-2028)
-
Figure China Neurodegenerative Diseases Drug Sales Volume Share, by Application (2017-2028)
-
Table China Neurodegenerative Diseases Drug Sales Value, by Application (2017-2028)
-
Table China Neurodegenerative Diseases Drug Sales Value Share, by Application (2017-2028)
-
Figure China Neurodegenerative Diseases Drug Sales Value Share, by Application (2017-2028)
-
Figure China Neurodegenerative Diseases Drug Production, Import, Consumption and Export (2017-2022)
-
Figure North America Neurodegenerative Diseases Drug Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Neurodegenerative Diseases Drug Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Neurodegenerative Diseases Drug Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Neurodegenerative Diseases Drug Production, Import, Consumption and Export (2017-2022)
-
Table North America Neurodegenerative Diseases Drug Sales Volume, by Type (2017-2028)
-
Table North America Neurodegenerative Diseases Drug Sales Volume Share, by Type (2017-2028)
-
Figure North America Neurodegenerative Diseases Drug Sales Volume Share, by Type (2017-2028)
-
Table North America Neurodegenerative Diseases Drug Sales Volume, by Application (2017-2028)
-
Table North America Neurodegenerative Diseases Drug Sales Volume Share, by Application (2017-2028)
-
Figure North America Neurodegenerative Diseases Drug Sales Volume Share, by Application (2017-2028)
-
Figure United States Neurodegenerative Diseases Drug Sales Volume and Growth Rate (2017-2028)
-
Figure United States Neurodegenerative Diseases Drug Sales Value and Growth Rate (2017-2028)
-
Figure Canada Neurodegenerative Diseases Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Neurodegenerative Diseases Drug Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Neurodegenerative Diseases Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Neurodegenerative Diseases Drug Sales Value and Growth Rate (2017-2028)
-
Table Europe Neurodegenerative Diseases Drug Sales Volume, by Type (2017-2028)
-
Table Europe Neurodegenerative Diseases Drug Sales Volume Share, by Type (2017-2028)
-
Figure Europe Neurodegenerative Diseases Drug Sales Volume Share, by Type (2017-2028)
-
Table Europe Neurodegenerative Diseases Drug Sales Volume, by Application (2017-2028)
-
Table Europe Neurodegenerative Diseases Drug Sales Volume Share, by Application (2017-2028)
-
Figure Europe Neurodegenerative Diseases Drug Sales Volume Share, by Application (2017-2028)
-
Figure Germany Neurodegenerative Diseases Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Neurodegenerative Diseases Drug Sales Value and Growth Rate (2017-2028)
-
Figure UK Neurodegenerative Diseases Drug Sales Volume and Growth Rate (2017-2028)
-
Figure UK Neurodegenerative Diseases Drug Sales Value and Growth Rate (2017-2028)
-
Figure France Neurodegenerative Diseases Drug Sales Volume and Growth Rate (2017-2028)
-
Figure France Neurodegenerative Diseases Drug Sales Value and Growth Rate (2017-2028)
-
Figure Italy Neurodegenerative Diseases Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Neurodegenerative Diseases Drug Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Neurodegenerative Diseases Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Neurodegenerative Diseases Drug Sales Value and Growth Rate (2017-2028)
-
Figure Spain Neurodegenerative Diseases Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Neurodegenerative Diseases Drug Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Neurodegenerative Diseases Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Neurodegenerative Diseases Drug Sales Value and Growth Rate (2017-2028)
-
Figure Poland Neurodegenerative Diseases Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Neurodegenerative Diseases Drug Sales Value and Growth Rate (2017-2028)
-
Figure Russia Neurodegenerative Diseases Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Neurodegenerative Diseases Drug Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Neurodegenerative Diseases Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Neurodegenerative Diseases Drug Sales Value and Growth Rate (2017-2028)
-
Table APAC Neurodegenerative Diseases Drug Sales Volume, by Type (2017-2028)
-
Table APAC Neurodegenerative Diseases Drug Sales Volume Share, by Type (2017-2028)
-
Figure APAC Neurodegenerative Diseases Drug Sales Volume Share, by Type (2017-2028)
-
Table APAC Neurodegenerative Diseases Drug Sales Volume, by Application (2017-2028)
-
Table APAC Neurodegenerative Diseases Drug Sales Volume Share, by Application (2017-2028)
-
Figure APAC Neurodegenerative Diseases Drug Sales Volume Share, by Application (2017-2028)
-
Figure China Neurodegenerative Diseases Drug Sales Volume and Growth Rate (2017-2028)
-
Figure China Neurodegenerative Diseases Drug Sales Value and Growth Rate (2017-2028)
-
Figure Japan Neurodegenerative Diseases Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Neurodegenerative Diseases Drug Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Neurodegenerative Diseases Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Neurodegenerative Diseases Drug Sales Value and Growth Rate (2017-2028)
-
Figure India Neurodegenerative Diseases Drug Sales Volume and Growth Rate (2017-2028)
-
Figure India Neurodegenerative Diseases Drug Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Neurodegenerative Diseases Drug Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Neurodegenerative Diseases Drug Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Neurodegenerative Diseases Drug Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Neurodegenerative Diseases Drug Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Neurodegenerative Diseases Drug Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Neurodegenerative Diseases Drug Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Neurodegenerative Diseases Drug Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Neurodegenerative Diseases Drug Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Neurodegenerative Diseases Drug Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Neurodegenerative Diseases Drug Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Neurodegenerative Diseases Drug Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Neurodegenerative Diseases Drug Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Neurodegenerative Diseases Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Neurodegenerative Diseases Drug Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Neurodegenerative Diseases Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Neurodegenerative Diseases Drug Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Neurodegenerative Diseases Drug Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Neurodegenerative Diseases Drug Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Neurodegenerative Diseases Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Neurodegenerative Diseases Drug Sales Value and Growth Rate (2017-2028)
-
Table Teva Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Teva Pharmaceuticals Product Profiles, Application and Specification
-
Table Teva Pharmaceuticals Neurodegenerative Diseases Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Mitsubishi Tanabe Pharma America Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Mitsubishi Tanabe Pharma America Product Profiles, Application and Specification
-
Table Mitsubishi Tanabe Pharma America Neurodegenerative Diseases Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table UCB SA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table UCB SA Product Profiles, Application and Specification
-
Table UCB SA Neurodegenerative Diseases Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Novartis Product Profiles, Application and Specification
-
Table Novartis Neurodegenerative Diseases Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Roche Product Profiles, Application and Specification
-
Table Roche Neurodegenerative Diseases Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table ACADIA Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table ACADIA Pharmaceuticals Inc Product Profiles, Application and Specification
-
Table ACADIA Pharmaceuticals Inc Neurodegenerative Diseases Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Sanofi Product Profiles, Application and Specification
-
Table Sanofi Neurodegenerative Diseases Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Orion Pharma Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Orion Pharma Ltd Product Profiles, Application and Specification
-
Table Orion Pharma Ltd Neurodegenerative Diseases Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Biogen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Biogen Product Profiles, Application and Specification
-
Table Biogen Neurodegenerative Diseases Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Lundbeck Pharmaceuticals Italy SpA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Lundbeck Pharmaceuticals Italy SpA Product Profiles, Application and Specification
-
Table Lundbeck Pharmaceuticals Italy SpA Neurodegenerative Diseases Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Pfizer Product Profiles, Application and Specification
-
Table Pfizer Neurodegenerative Diseases Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
